5 | Pharmaceutical PreparationsIBA
01/2022
-
08/2002 |
4 | Tyrosine Kinase InhibitorsIBA
04/2022
-
05/2010 |
4 | PlatinumIBA
01/2022
-
01/2017 |
3 | ErbB Receptors (EGF Receptor)IBA
04/2022
-
01/2020 |
3 | osimertinibIBA
01/2022
-
01/2020 |
3 | pembrolizumabIBA
01/2022
-
01/2017 |
3 | LigandsIBA
01/2021
-
09/2015 |
3 | Tyrosine (L-Tyrosine)FDA Link
01/2021
-
04/2013 |
3 | Phosphotransferases (Kinase)IBA
01/2021
-
11/2008 |
3 | thymidine kinase 1IBA
04/2016
-
08/2010 |
2 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022
-
01/2021 |
2 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
-
01/2019 |
2 | Drug CombinationsIBA
01/2022
-
01/2021 |
2 | Proteins (Proteins, Gene)FDA Link
01/2021
-
01/2021 |
2 | Serine (L-Serine)FDA Link
11/2018
-
09/2017 |
2 | Lysine-tRNA LigaseIBA
11/2018
-
09/2017 |
2 | Microphthalmia-Associated Transcription FactorIBA
09/2015
-
09/2002 |
2 | Cytotoxins (Cytolysins)IBA
10/2014
-
05/2008 |
2 | Interleukin-4 (Interleukin 4)IBA
11/2009
-
04/2005 |
2 | OvalbuminIBA
05/2008
-
10/2007 |
1 | AutoantibodiesIBA
09/2021 |
1 | Alanine Transaminase (SGPT)IBA
01/2021 |
1 | human ERBB2 proteinIBA
01/2021 |
1 | CrizotinibIBA
01/2021 |
1 | Anaplastic Lymphoma KinaseIBA
01/2021 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
01/2021 |
1 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2021 |
1 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 |
1 | Gefitinib (Iressa)FDA Link
01/2020 |
1 | Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 |
1 | Biomarkers (Surrogate Marker)IBA
11/2019 |
1 | Platinum Compounds (Compounds, Platinum)IBA
11/2019 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2018 |
1 | B7-H1 AntigenIBA
01/2018 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2017 |
1 | cabozantinibIBA
11/2016 |
1 | pro-gastrin-releasing peptide (31-98)IBA
02/2016 |
1 | Peptides (Polypeptides)IBA
02/2016 |
1 | big gastrinIBA
02/2016 |
1 | NivolumabIBA
01/2016 |
1 | MicroRNAs (MicroRNA)IBA
06/2015 |
1 | Disulfiram (Antabuse)FDA Link
04/2015 |
1 | Cisplatin (Platino)FDA LinkGeneric
04/2015 |
1 | Vinorelbine (Navelbine)FDA LinkGeneric
04/2015 |
1 | Growth Factor ReceptorsIBA
10/2014 |
1 | Cetuximab (Erbitux)FDA Link
08/2014 |
1 | taxaneIBA
08/2014 |
1 | Taxoids (Taxanes)IBA
08/2014 |
1 | Formaldehyde (Formol)FDA Link
02/2012 |
1 | ParaffinIBA
02/2012 |
1 | EnzymesIBA
08/2010 |
1 | Pyruvate KinaseIBA
08/2010 |
1 | masitinibIBA
05/2010 |
1 | pazopanibFDA Link
05/2010 |
1 | Imatinib Mesylate (Gleevec)FDA Link
05/2010 |
1 | Interleukin-21 ReceptorsIBA
01/2010 |
1 | interleukin-21 (interleukin 21)IBA
01/2010 |
1 | DNA (Deoxyribonucleic Acid)IBA
02/2009 |
1 | Interferon-gamma (Interferon, gamma)IBA
05/2008 |
1 | CytokinesIBA
05/2008 |
1 | AntigensIBA
10/2007 |
1 | Bromodeoxyuridine (BrdU)IBA
10/2007 |
1 | Atrial Natriuretic Factor (ANF)IBA
10/2006 |
1 | Transcription Factors (Transcription Factor)IBA
10/2006 |
1 | Adrenergic Agents (Adrenergic Drugs)IBA
10/2006 |